Company / Assets per Share
Alaunos Therapeutics, Inc. Assets per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.85
FY2025
5-year range
$0.30 / $1.85
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has increased for 3 consecutive years, from $0.30 in FY2022 to $1.85 in FY2025.
Based on SEC 10-K filings.
1.85 in FY2025 with a 5-year CAGR of +18.1%.
Improved from $0.52 to $1.85 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +83.4%
- 5-Year CAGR
- +18.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Alaunos Therapeutics, Inc.'s assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 7.7% year-over-year.
- Lowest assets per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.85 | +7.7% |
| FY2024 | $1.72 | +233.7% |
| FY2023 | $0.52 | +71.6% |
| FY2022 | $0.30 | -32.0% |
| FY2021 | $0.44 | -45.1% |
| FY2020 | $0.80 | +18.8% |
| FY2019 | $0.68 | +1.7% |
| FY2018 | $0.67 | -22.7% |
| FY2013 | $0.86 | -28.5% |
| FY2012 | $1.21 | -46.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026